Lametec 50 DT Tablet contains Lamotrigine 50 mg, an anticonvulsant medication primarily indicated for the treatment of epilepsy and bipolar disorder. Lamotrigine acts by stabilizing neuronal membranes and modulating voltage-sensitive sodium channels, thereby inhibiting the release of excitatory neurotransmitters such as glutamate. This mechanism helps to prevent the initiation and spread of seizure activity in the brain. Lametec 50 DT is effective in managing partial seizures, generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome. Additionally, it is utilized as a mood stabilizer to reduce the frequency and severity of mood episodes in bipolar disorder, particularly in the prevention of depressive episodes. The tablet is designed for rapid disintegration, facilitating ease of administration, especially in patients with swallowing difficulties. Lametec 50 DT should be initiated at a low dose with gradual titration to minimize the risk of serious adverse effects, including rash and hypersensitivity reactions. Common side effects may include dizziness, headache, blurred vision, and nausea. It is essential to monitor patients closely during therapy and adjust the dose accordingly. Lametec 50 DT should be used under medical supervision, with caution advised in patients with a history of hypersensitivity to Lamotrigine or other anticonvulsants.